Algorithmic Biologics

Private

ALGORITHMIC BIOLOGICS PRIVATE LIMITED

Private

ALGORITHMIC BIOLOGICS PRIVATE LIMITED

2021

Founded in 2021, Algorithmic Biologics operates in Health Tech industry. Originally focused on enhancing DNA synthesis and sequencing processes, the company has evolved to incorporate machine learning...

Funding stage:

Seed

Last funding:

02/02/2024

Total funding:

$2.49 Mn+

Revenue:

₹1.6 Cr+ (FY25)

Prev. FY

Investors

Employee count:

Last 90d

Web traffic:

1.58K

Last 30d

Glassdoor Rating:

Algorithmic Biologics: Financial Breakdown

Decoding financial health metrics of Algorithmic Biologics

Total Revenue
₹1.6 Cr
322%
Prev. FY
Total Expenses
₹1.1 Cr
-32%
Prev. FY
Profit After Tax
₹55.0 Lakh
146%
Prev. FY
Total Assets
₹21.7 Cr
0%
Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of Algorithmic Biologics

No. In FY25, Algorithmic Biologics reported a net loss of ₹23.7 Lakh, so it was not profitable.

Algorithmic Biologics's revenue grew 322.2% year-on-year, from ₹38.7 Lakh in FY24 to ₹1.6 Cr in FY25.

In FY25, Algorithmic Biologics posted revenue of ₹1.6 Cr (up 322.2% YoY) and a net loss of ₹23.7 Lakh. Explore the full financials of Algorithmic Biologics here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

Algorithmic Biologics - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Algorithmic Biologics: Financial Breakdown

FAQs on Financials of Algorithmic Biologics

Is Algorithmic Biologics profitable?

What is Algorithmic Biologics's growth rate?

How is Algorithmic Biologics's business performing?

Disclaimer